Back to News
Market Impact: 0.2
Starpharma Holdings Limited - Depositary Receipt Price Target Increased by 59.26% to $9.02
Source: Nasdaq
Analyst InsightsAnalyst Estimates
The average one-year price target for Starpharma Holdings Limited depositary receipts (OTCPK: SPHRY) was revised to $9.02 per share, up 59.26% from the prior $5.66 estimate dated June 8, 2026. The article provides no further details on the analysts or the basis for the revision.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Jefferies raises Zymeworks stock price target on Roche deal
- Truist raises United Rentals stock price target on strong margins
- Century Casinos receives Nasdaq notice for minimum market value deficiency
- GM stock analysis: cheap valuation meets falling estimates after earnings drop